Medicinal cannabis is one of the fastest growing areas of modern medicine — yet it remains widely misunderstood.In this episode of The Revital Health Podcast, Jodi Duval speaks with Matt Shales, CEO and Co-Founder of MediCann Health, about the evolving medicinal cannabis industry in Australia and the science behind producing high-quality cannabis medicine.Together they explore how cultivation, genetics, extraction methods, and rigorous testing all influence the safety and effectiveness of cannabinoid therapies.The conversation moves beyond stigma and headlines to examine what truly defines a pharmaceutical-grade cannabis product and why quality control is critical for patient outcomes.They also discuss the rapid expansion of medicinal cannabis prescribing in Australia, the role of clinical research, and the future of cannabinoid medicine.In this episode we discuss:How medicinal cannabis is grown and why genetics matterThe importance of cultivation methods and environmental controlTerpenes, cannabinoids, and the “entourage effect”What defines a high-quality medicinal cannabis productThe challenges of regulation, stigma, and educationThe future of cannabis research and clinical trials in AustraliaThis episode offers a fascinating insight into how a complex plant is being transformed into a regulated therapeutic medicine.Connect with Matt ShalesWebsite www.medicannhealth.com.auSocials Facebook: Medicann Health LinkedIn: Medicann Health Instagram: @medicannhealth

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related